Dendritic cells pulsed with prostate-specific membrane antigen in metastatic castration-resistant prostate cancer patients: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Dendritic cells pulsed with prostate-specific membrane antigen in metastatic castration-resistant prostate cancer patients: a systematic review and meta-analysis

Published:2018-12 Issue:4 Volume:6 Page:119-125
ISSN:2287-8882
Container-title:Prostate International
language:en
Short-container-title:Prostate International

Author:

Mohammadzadeh Mohammad,Shirmohammadi Masoud,Ghojazadeh Morteza,Nikniaz Leila,Raeisi Mortaza,Aghdas Seyed Ali Mousavi

Publisher

Elsevier BV

Subject

Urology

Reference51 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program;Hayat;The Oncologist,2007

3. Evaluation and Treatment of Men with Biochemical Prostate-Specific Antigen Recurrence Following Definitive Therapy for Clinically Localized Prostate Cancer;Pound;Rev Urol,2001

4. Prostate Cancer Trends 1973–1995;Stanford,1999

5. Abiraterone in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and MDV3100;Ileana;Am Soc Clin Oncol,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs appropriately?;Critical Reviews in Oncology/Hematology;2024-04

2. Current approaches to quality assessment, non-clinical and clinical studies of dendritic cell vaccines in oncology;Biological Products. Prevention, Diagnosis, Treatment;2023-04-28

3. The efficacy and safety of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis;Medicine;2022-08-05

4. Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8+ T cell immune responses;Drug Delivery and Translational Research;2019-06-21

5. Differences of the immune cell landscape between normal and tumor tissue in human prostate;Clinical and Translational Oncology;2019-05-10